Christopher Anzalone
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arrowhead Pharmaceuticals, Inc. (ARWR) | President and Chief Executive Officer | $951,012 | $12,423,473 |
| 2023 | Arrowhead Pharmaceuticals, Inc. (ARWR) | President and Chief Executive Officer | $902,522 | $9,918,093 |
| 2022 | Arrowhead Pharmaceuticals, Inc. (ARWR) | President and Chief Executive Officer | $863,417 | $12,031,969 |
| 2021 | Arrowhead Pharmaceuticals, Inc. (ARWR) | President and Chief Executive Officer | $837,031 | $24,703,855 |
| 2020 | Arrowhead Pharmaceuticals, Inc. (ARWR) | President and Chief Executive Officer | $785,625 | $14,294,517 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.